Revive Therapeutics Ltd.
RVVTF
$0.01
$0.00-6.49%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -204.60K | -6.94M | -402.20K | -260.50K | -346.40K |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.30K | 6.88M | 75.90K | 7.10K | 4.20K |
| Change in Net Operating Assets | 35.90K | 54.10K | 274.60K | 97.90K | -2.50K |
| Cash from Operations | -103.40K | -4.30K | -51.60K | -155.40K | -344.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -22.00K |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | -22.00K |
| Total Debt Issued | -- | 0.00 | 65.00K | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -25.80K |
| Issuance of Common Stock | 148.80K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -25.80K | 0.00 | 0.00 | 25.80K |
| Cash from Financing | 108.00K | -18.70K | 45.30K | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.60K | -23.00K | -6.30K | -155.40K | -366.60K |